MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change

R.J. Elble (Springfield, IL, USA)

Meeting: 2016 International Congress

Abstract Number: 982

Keywords: Essential tremor(ET), Neurophysiology, Scales

Session Information

Date: Tuesday, June 21, 2016

Session Title: Tremor

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To determine if a digitizing tablet is better than Fahn-Tolosa-Marín part B (FTM-B) ratings in detecting changes in essential tremor (ET) that exceed random variability in tremor amplitude.

Background: Tremor rating scales provide crude, nonlinear, subjective assessments of tremor severity. By contrast, digitizing tablets are capable of providing precise, linear, objective measures of tremor in writing and drawings. However, the advantages of tablets over rating scales are diminished when random variability in tremor is large. Tablets will measure random variability precisely, but changes in tremor must exceed random variability to be recognizable as true change due to a treatment or disease progression.

Methods: The large and small spirals of FTM-B were drawn by 18 patients with mild to severe ET in an unpublished open-label pharmacokinetic/pharmacodynamic study of sodium oxybate. Baseline assessments on consecutive days were used to compute test-retest reliability (intraclass correlation) and minimum detectable change (MDC) for the FTM ratings and digitizing tablet measurements. Regression between FTM ratings and log (base 10) digitizing tablet measurements was computed to obtain the Weber-Fechner relationship. Tremor amplitude in each digitized drawing was computed using spectral analysis (Elble et al. Mov Disord 1996;11:70-78) by a technician who was blinded to the tremor ratings. The grand average of peak-to-peak tremor displacement (cm) in the four spirals (2 spirals, right and left hands) was compared with the grand average of the four FTM ratings.

Results: Regression analysis revealed a very strong linear Weber-Fechner relationship between FTM and log(tablet) for baseline 1 (log(tablet) = 0.59 FTM – 1.24, r = 0.95) and baseline 2 (log(tablet) = 0.61 FTM – 1.29, r = 0.94). The MDC for the digitizing tablet was 50% of the baseline geometric mean tremor amplitude. The MDC for FTM was 90% of mean baseline rating. Using the Weber-Fechner equation (slope = 0.6), the FTM score was converted to actual tremor amplitude (Deuschl et al. Lancet Neurol 2011;10:148-161), and the MDC for the converted FTM ratings was 66%.

Conclusions: The variability in ET amplitude is so great that MDC of the digitizing tablet (i.e., the smallest change exceeding random variability) is comparable to MDC of FTM-B tremor ratings. Detectable change in ET is limited by its considerable natural variability over time.

To cite this abstract in AMA style:

R.J. Elble. Digitizing tablet and Fahn-Tolosa-Marín tremor ratings have comparable minimum detectable change [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/digitizing-tablet-and-fahn-tolosa-marn-tremor-ratings-have-comparable-minimum-detectable-change/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/digitizing-tablet-and-fahn-tolosa-marn-tremor-ratings-have-comparable-minimum-detectable-change/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley